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Abstract
Background: Pre-existing polyps, especially large polyps, are known to be the major source for colorectal cancer,
but there is limited available information about factors that are associated with polyp size and polyp growth. We
aim to determine factors associated with polyp size in different age groups.
Methods: Colonoscopy data were prospectively collected from 67 adult gastrointestinal practice sites in the United
States between 2002 and 2007 using a computer-generated endoscopic report form. Data were transmitted to and
stored in a central data repository, where all asymptomatic white (n = 78352) and black (n = 4289) patients who
had a polyp finding on screening colonoscopy were identified. Univariate and multivariate analysis of age, gender,
performance site, race, polyp location, number of polyps, and family history as risk factors associated with the size
of the largest polyp detected at colonoscopy.
Results: In both genders, size of the largest polyp increased progressively with age in all age groups (P < .0001). In
subjects ≥ 80 years the relative risk was 1.55 (95% CI, 1.35-1.79) compared to subjects in the youngest age group.
With the exception of family history, all study variables were significantly associated with polyp size (P < .0001),
with multiple polyps (≥ 2 versus 1) having the strongest risk: 3.41 (95% CI, 3.29-3.54).
Conclusions: In both genders there is a significant increase in polyp size detected during screening colonoscopy
with increasing age. Important additional risk factors associated with increasing polyp size are gender, race, polyp
location, and number of polyps, with polyp multiplicity being the strongest risk factor. Previous family history of
bowel cancer was not a risk factor.
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Background
Globally, colorectal cancer is now the fourth commonest
tumor in males and the third most frequent tumor in
females[1]. Numerous studies have confirmed the strong
relationship between colorectal polyps and colorectal
cancer and there is universal agreement that pre-existing
polyps are the major risk factor leading to the subse-
quent development of colorectal cancer[2]. Polyps with
advanced histological features are especially likely to be
premalignant[3].
It has been well documented that the proportion of
polyps harboring advanced histologic features increases
with the polyp size. For example, polyps less than 5 mm
rarely have worrisome pathologic features, in contrast to
polyps ≥ 10 mm where about one third will have
advanced histology[4-6].
Information about determinants of polyp size could be
potentially informative for recommendations about the
age of onset of initial screening, the interval between
screening procedures, and the type of screening proce-
dure to be employed.
However, despite the strong link between polyp size
and the subsequent development of malignancy, rela-
tively few studies have investigated age-related changes
in polyp size or have investigated risk factors leading to
the growth of polyps[5-7]. The main reason for the pau-
city of information on polyp growth is that such studies
generally require repeated observations on polyps that
have been left in situ, rather than being removed. How-
ever, since even small polyps can be occasionally malig-
nant, observing rather than resecting polyps leads to
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formed generally have contained only a few patients,
thus limiting their inferential power. Some have been
performed almost 50 years ago and were based on indir-
ect repeated measurements of colorectal polyps
observed by serial barium enemas.
To obtain quantitative information about risk factors
that determine polyp size we have used stored observa-
tional data on polyp size from a large database of
patients undergoing screening colonoscopy. The primary
study aim was to determine risk factors that are related
to polyp size in males and females. We hypothesized
that in addition to previously determined factors such as
age and race, other factors such as family history of col-
orectal cancer, gender, anatomic location of the polyp,
and number of polyps might be important predictors of
polyp size.
Methods
Data source
The data included in this report were obtained from a
consortium of 535 physicians practicing at 67 practice
sites in 26 states, who participate in the Clinical Out-
comes Research Initiative( C O R I )u s i n gp r e v i o u s l y
described methodology[8,9]. Briefly, all cooperating cen-
ters used the same computerized form to transmit data
obtained from colonoscopic procedures to a central reg-
istry where the data are subjected to quality control and
then merged. The CORI database is a limited dataset,
and does not contain patient contact information such
as name or address. This project was approved by the
Oregon Health & Science University institutional review
board.
Patients
Patients came from three separate sources: private prac-
tice (79%), academic sites (10%), and patients treated by
the Department of Veterans Affairs (11%). Patients
underwent screening colonoscopy in both urban and
rural sites.
We collected data from patients ≥ 18 years under-
going first colonoscopy at a CORI-participating site dur-
ing the study period without prior symptoms or signs
such as pain or bleeding, and without known colorectal
cancer syndromes during the period 2002 to 2007.
Patients diagnosed with polyps during the procedure
were considered for inclusion in the study. From the
available colonoscopy patient database we excluded
records of patients missing data about polyp size (n =
3899) or location (n = 4103), and an additional 213
patients with polyps > 40 mm, leaving 82641 patients
for analysis.
Mandatory variables included on the initial data col-
lection form and used for this study were: age, gender,
race (black non-Hispanic, white non-Hispanic), type of
practice, size of the largest polyp detected at colono-
scopy, number of polyps (single versus ≥ 2), any family
history of colorectal cancer (positive, negative) and
polyp location defined as proximal or distal to the sple-
nic flexure. Histologic results were available for some
patients, but no information about any type of histologic
finding was included in the present study because only
approximately 25% of CORI sites enter pathology data.
Classification of race (White or Black) was provided by
the endoscopist; these two categories accounted for >
90% of all patients in the database.
Statistical analysis
Patient age was stratified by decade with additional cate-
gories for patients < 50 years and ≥ 80 years. For uni-
variate analysis of mean polyp size and 95% confidence
limits, we used chi-square tests and t-tests to study age-
related size differences in subgroups stratified by gender,
race, polyp location, and number of polyps.
We used ordinal logistic regression to obtain multi-
variate adjusted estimates with 95% confidence intervals.
Ordinal logistic regression is a proportional odds model
that allowed us to generate odds ratios measuring the
risk associated with an increase of polyp size corre-
sponding to moving from one category to the next lar-
ger size category. For this analysis we stratified polyps
by size into four groups: 0-5 mm, 5.1-9.0 mm, 9.1-15
mm, and 15-40 mm. The method assumes similar odds
ratios associated with transition from one group to the
next larger group. We tested this assumption, which
proved to be accurate for our data set, allowing us to
provide a common odds ratio for each of the variables
studied. Variables included in the multivariate adjusted
model included age, sex, race, number of polyps, loca-
tion of polyp (proximal or distal), procedure site. Any
family history of colorectal cancer was included as a
variable because it has been previously reported to be a
predictor of polyp growth[10,11]. Because of a statisti-
cally significant interaction between gender and other
variables, we present separate multivariate-adjusted data
for males and females. To insure inclusion of all patients
with polyps in the study we excluded polyps > 40 mm
on the assumption that lesions > 40 mm were unlikely
to be polyps. All analytic procedures were carried out
with SAS (version 9.1; SAS Institute Inc, Cary, North
Carolina).
Results
Table 1 provides information about patient (n = 82641)
and polyp characteristics stratified by the size of the lar-
gest detected polyp. The mean age of all patients was
60.9 ± 9.2 years of age. Forty one percent of patients
were females and Blacks represented 5.2% of the total
Lowenfels et al. BMC Gastroenterology 2011, 11:101
http://www.biomedcentral.com/1471-230X/11/101
Page 2 of 8group. Almost 80% of colonoscopies were performed in
community or HMO settings; polyps detected in
patients undergoing colonoscopy in these types of prac-
tices were larger than in either academic or VA or mili-
tary sites (Table 1). In the entire data set more than half
of all polyps were small, measuring ≤ 5 mm; polyps 9-
15 mm represented about 12-15% of the entire group,
and polyps > 15 mm were rare, constituting < 5% of all
polyps. With increasing age, smaller polyps became less
common, while larger polyps increased in frequency.
Approximately two-thirds of patients had a single polyp
and family history of colorectal cancer was reported to
be negative in three-fourths of patients.
Table 2 and Figure 1 demonstrate that for all patients
and all subgroups, mean polyp size increases steadily
with age. In all age groups, polyps were larger in males
than in females, in Blacks than in Whites, proximal
polyps were larger than distal polyps, and multiple
polyps were larger than single polyps. (P <. 0 0 0 1 )O v e r -
all, mean polyp size was larger in polyps removed in a
Community or HMO site than in other sites, but the
results were not consistent across all age groups. The
presence or absence of a positive family history for
bowel cancer did not appear to influence age-related
changes in mean polyp size.
Table 3 lists the separate results of multivariate ordi-
nal logistic regression for males and females. In general,
the results resemble the findings resulting from the size/
age analysis using mean polyp size, but the results are
adjusted for all other study variables. The number of
polyps found at colonoscopy (1, ≥ 2) proved to be the
strongest predictor of age-related increase in polyp size.
Discussion
Only a few previous studies have looked at polyp growth
rates based on observed changes over time in patients
with unresected polyps. In an early study, Welin and co-
workers estimated the growth of tumors and colorectal
polyps based on change of observed size in patients with
multiple barium enema studies[6]. The study included
17 patients with adenomatous polyps who were followed
for up to ten years after the initial polyp detection. The
Table 1 Patient demographics by polyp size
Polyp Size
0 - 5 mm > 5 - 9 mm > 9 - 15 mm > 15 mm Total
n (%) n (%) N (%) n (%) n
All Subjects 48947 (59.2) 19422 (23.5) 11240 (13.6) 3032 ( 3.7) 82641
Age
< 50 3097 (63.4) 1073 (22.0) 587 (12.0) 125 ( 2.6) 4882
50-59 22859 (61.8) 8433 (22.8) 4613 (12.5) 1081 ( 2.9) 36986
60-69 14913 (57.3) 6259 (24.1) 3809 (14.6) 1035 ( 4.0) 26016
70-79 6991 (55.0) 3149 (24.8) 1905 (15.0) 658 ( 5.2) 12703
80+ 1087 (52.9) 508 (24.7) 326 (15.9) 133 ( 6.5) 2054
Gender
Male 28002 (57.9) 11502 (23.8) 6982 (14.4) 1909 ( 2.3) 48395
Female 20945 (61.2) 7920 (23.1) 4258 (12.4) 1123 ( 3.3) 34246
Site
Academic 4864 (64.4) 1506 (19.9) 928 (12.3) 257 ( 3.4) 7555
Community/HMO 38503 (58.4) 15909 (24.1) 9019 (13.7) 2491 ( 3.8) 65922
VA/Military 5580 (60.9) 2007 (21.9) 1293 (14.1) 284 ( 3.1) 9164
Race
White 46601 (59.5) 18436 (23.5) 10506 (13.4) 2809 ( 3.6) 78352
Black 2346 (54.7) 986 (23.0) 734 (17.1) 223 ( 5.2) 4289
Location
Proximal Colon 20013 (55.6) 9266 (25.7) 5198 (14.4) 1524 ( 4.2) 36001
Distal Colon and, Rectum 28934 (62.0) 10156 (21.8) 6042 (13.0) 1508 ( 3.2) 46640
Number of polyps
Single 38027 (69.1) 10676 (19.4) 5057 ( 9.2) 1295 ( 2.4) 55055
Multiple 10920 (39.6) 8746 (31.7) 6183 (22.4) 1737 ( 6.3) 27586
Family history
Negative 37015 (59.1) 14669 (23.4) 8642 (13.8) 2322 ( 3.7) 62648
Positive 11932 (59.7) 4753 (23.8) 2598 (13.0) 710 ( 3.6) 19993
*Numbers in brackets = percent of row total.
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pathologically proven polyps and cancer, that growth
rates were generally slow even for cancers, and that it
was impossible to distinguish between linear and expo-
nential growth rates.
After the advent of colonoscopy, a few follow-up stu-
dies of polyps detected and marked at the time of the
initial screening examination have been performed.
Hofsted and co-workers studied 58 patients over a three
year period and found that 40% of polyps became larger,
27% were unchanged, and in 35% there was an apparent
reduction in size[7]. Approximately half of the polyps
included in the study were ≤ 4mm, so that measuring
exact change in size would have been problematic. In a
more recent study where 26 patients with marked
polyps were followed over a period of two years, the
findings were similar with inconsistent growth rates, and
again, some polyps appeared to diminish in size during
the study period[12]. Kozo, in a study of 33 patients
enrolled in the placebo arm of a therapeutic trial found
that polyp size increased about 5% per year but with
wide variation[13].
These comparatively small studies imply that polyp
growth rates are inconsistent and that in some cases
polyps diminish in size over time. Data from a modeling
exercise based on the national polyp data postulated
that a regression in polyp size could explain the
discrepancy between the large number of polyps in the
population and the observed incidence of colorectal can-
cer[14].
In our study, mean differences in polyp size were pre-
sent for study variables in most age groups and were
initially observed in the youngest patient groups. Size dif-
ferences were particularly striking for the number of
polyps: in both univariate and multivariate analysis multi-
plicity of polyps, present in about one-third of patients,
was the strongest risk factor for polyp size. The size of
the largest polyp in patients with multiple polyps was
approximately 50% larger than the largest polyp found in
patients with only a single polyp. This finding suggests
that either the growth pattern of multiple polyps is more
aggressive than single polyps, or that initial polyp forma-
tion in patients with multiple polyps begins considerably
earlier than in patients with as i n g l ep o l y p .T h i sf i n d i n g
provides strong evidence supporting the recommenda-
tion that the screening interval in patients with multiple
polyps be shorter than for patients with single polyps[15].
This study confirms and extends the previously
reported findings from the CORI database relating to age
and race as determinants of polyp size[9,16]. In both uni-
variate and multivariate analysis, these two variables were
strongly associated with polyp size in all age groups. In
addition, gender, polyp location, and number of polyps
were also found to be associated with polyp size.
Table 2 Variables associated with mean size of largest polyp (mm) in each age group of patients*
Age Group
Variable < 50 n = 3097 50-59 n = 22859 60-69 n = 14913 70-79 n = 6991 80 + n = 1087
Gender
Male 5.88 (5.72-6.0)** 6.1 (6.04-6.16) 6.64 (6.56-6.72) 6.88 (6.76-7.00) 7.45 (7.08-7.82)
Female 5.74 (5.56-5.92) 5.76 (5.69-5.83) 6.15 (6.06-6.24) 6.64 (6.51-6.77) 7.03 (6.68-7.38)
Site
Academic 5.43 (5.07-5.79) 5.62 (5.47-5.77) 6.03 (5.83-6.23) 6.18 (5.92-6.44) 6.70 (5.83-7.57)
Community/HMO 5.88 (5.75-6.01) 5.99 (5.94-6.04) 6.51 (6.44-6.58) 6.87 (6.77-6.97) 7.27 (7.00-7.54)
VA/Military 5.68 (5.28-6.08) 5.98 (5.85-6.11) 6.28 (6.12-6.44) 6.60 (6.27-6.93) 7.60 (6.37-8.83)
Race
White 5.77 (5.65-5.89) 5.93 (5.89-5.97) 6.40 (6.34-6.46) 6.74 (6.65-6.83) 7.19 (6.94-7.44)
Black 6.63 (5.95-7.31) 6.46 (6.26-6.66) 7.21 (6.89-7.53) 7.66 (7.09-8.23) 9.05 (6.94-11.16)
Polyp location
Distal 5.60 (5.46-5.74) 5.79 (5.73-5.85) 6.19 (6.12-6.26) 6.54 (6.42-6.66) 6.91 (6.58-7.24)
Proximal 6.18 (5.98-6.38) 6.20 (6.13-6.27) 6.75 (6.66-6.84) 7.02 (6.88-7.16) 7.55 (7.17-7.93)
Number of polyps
Single 5.12 (5.00-5.24) 5.21 (5.16-5.26) 5.53 (5.47-5.59) 5.85 (5.75-5.95) 6.29 (6.01-6.57)
Multiple 7.52 (7.25-7.79) 7.58 (7.49-7.67) 8.10 (7.99-8.21) 8.44 (8.27-8.61) 9.02 (8.54-9.50)
Family history
Negative 5.80 (5.53-6.07) 5.93 (5.88-5.98) 6.43 (6.36-6.50) 6.84 (6.74-6.94) 7.29 (7.01-7.57)
Positive 5.82 (5.69-5.89) 6.07 (5.97-6.17) 6.50 (6.37-6.63) 6.49 (6.29-6.69) 7.04 (6.47-7.61)
All patients 5.82 (5.70-5.94) 5.96 (5.92-6.00) 6.44 (6.38-6.50) 6.78 (6.69-6.87) 7.25 (7.00-7.50)
*Group data are based upon averages of the single largest polyp in millimeters detected in each individual patient in that group. **Numbers in brackets = 95%
confidence interval.
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collected in the CORI data set. Polyp formation has
been related to factors such as smoking, alcohol and
obesity and these factors could be important for polyp
growth[17-21]. Additional studies need to be per-
formed to determine the relationship between factors
that predict polyp size reported here and environmen-
tal and genetic factors. Factors such as age, gender,
polyp location and polyp multiplicity along with envir-
onmental factors are likely to affect mutational rates of
crypt cells causing differences in the growth rates of
polyps. Genetic factors which lead to genetic instability
and which affect the growth rate of precursors of col-
orectal cancer undoubtedly play an important role
[22,23]. Smoking and alcohol drinking are more preva-
lent in males and might explain the male/female differ-
ences in polyp size. It is of interest that a recent report
based on colonoscopy screening in a different cohort
found that smoking was significantly related to polyp
size[24].
Family history of bowel cancer was not a predictor of
polyp size in our data set. Our finding agrees with
results from a smaller study based on the same CORI
data where pathologic data were indicated that a posi-
tive family history for bowel cancer was not associated
with an increased proportion of patients with advanced
neoplasia[4]. Our results about family history contrast
with the results of a direct observational study of polyp
growth, where family history appeared to be a risk factor
for polyp growth[10]. However this study was based on
only 14 patients with a positive family history of bowel
cancer who had been enrolled in the placebo arm of a
randomized trial. In a follow-up study of patients after
an initial screening colonoscopy, Nusko and co-workers
found that a positive family history of colorectal cancer
increased the risk of developing a metachronous tubular
adenoma[11].
The strengths of this study relate to the large number
of colonoscopies performed in various settings, with uni-
formity of data collection maintained by using a single
reporting form. The procedures were carried out in two
different racial groups in a variety of settings, so that
the findings are likely to be valid for the general
population.
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Figure 1 Age-related differences in mean polyp size and 95% confidence intervals in relation to gender (A), race (B), location in colon
(C), and single versus multiple polyps (D). Upper limit for 95% confidence limit for Blacks was 11.16.
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because pathologic information was unavailable for
patients from three-quarters of the centers, we did not
include this variable in the analysis. Restricting the data
set to those patients with a confirmed pathologic diag-
nosis would have greatly reduced the power of the
study. By setting the upper limit of polyp size at 4 cm, it
is likely we have captured all polyps detected at screen-
ing colonoscopy, but predictably, the data set includes
patients with advanced histology. A previous report pro-
vides pathologic information based on nearly 6,000
patients included in the CORI database undergoing
screening colonoscopy where pathologic information
was available [4]. Based on this report, we estimate that
about 8% of polyps in the current study would have
been classified as having advanced histology including
cancer, 51% a tubular adenoma, and 41% of patients
would have a non-neoplastic (hyperplastic, inflamma-
tory, lymphoid tissue) lesion.
Although the results are based on the initial screening
at a participating center, it is possible that some patients
may have had a previous examination in a non-partici-
pating center prior to being examined at a participating
center. It is possible that patients with a positive family
history, and those patients visiting academic, VA or
military centers, would be more likely to have under-
gone prior examinations and that black patients might
have been less likely to have had a prior colonoscopy. If
so, then this differential exposure to a prior screening
colonoscopy could partially explain some of our
findings.
We performed multivariate analysis using available
i n f o r m a t i o n .H o w e v e rw ew e r eu n a b l et oa d j u s tf o r
either lifestyle factors or genetic factors; if available
these additional factors might have altered our findings.
Another study weakness is that there is likely to be
measurement error of recorded polyp size leading to
misclassification of polyp size. We believe this measure-
ment error is likely to be bi-directional and based upon
a previous sensitivity analysis of polyp size in CORI
data, is unlikely to invalidate the findings. The analysis
was limited to patients who underwent a first colono-
scopy at a CORI-participating site during the study per-
iod, but we do not have information on whether the
procedure was the patient’s first ever, or just their first
in the study period. Although this adds uncertainty
about what we are measuring (a small polyp or lack of
any polyp could occur in a patient who had prior
Table 3 Multivariate ordinal logistic regression analysis of risk factors associated with polyp size in males and females
Males (n = 48,395) Females (n = 34,246)
OR (95% CI) OR (95% CI)
Age
< 50 1.00 1.00
50 - 59 1.06 (0.98 - 1.16) 1.00 (0.91 - 1.11)
60 - 69 1.29 (1.18 - 1.40)** 1.14 (1.03 - 1.26)*
70 - 79 1.36 (1.24 - 1.49)** 1.34 (1.20 - 1.49)**
80+ 1.55 (1.35 - 1.79)** 1.46 (1.25 - 1.70)**
Site
Academic 1.00 1.00
Community/HMO 1.26 (1.18 - 1.34)** 1.22 (1.13 - 1.33)**
VA/Military 0.97 (0.90 - 1.05) 0.90 (0.78 - 1.03)
Race
White 1.00 1.00
Black 1.31 (1.21 - 1.42)** 1.36 (1.24 - 1.48)**
Location
Distal Colon and rectum 1.00 1.00
Proximal Colon 1.11 (1.08-1.15)** 1.33 (1.27-1.39)**
Number of polyps
Single 1.00 1.00
Multiple 3.41 (3.29 - 3.54)** 3.04 (2.90 - 3.18)**
Family history
Negative 1.00 1.00
Positive 1.00 (0.95 - 1.05) 1.03 (0.98 - 1.08)
All odds ratios are adjusted for all other covariates in the table. * P < .01 **P < .0001
Odds Ratios (OR) and 95% Confidence Intervals (CI) obtained from ordinal logistic regression. Polyp size was stratified into 4 categories: 0-5, > 5-9, > 9-15, and >
15-40 mm. The odds ratio is the risk associated with an increase of polyp size corresponding to moving from one category to the next larger category, i.e. ≤ 5
mm vs. > 5 mm; ≤ 9 vs. > 9; ≤ 15 vs. > 15 mm.
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our findings, as older patients are certainly more likely
to have had prior screening compared to younger
patients. A final weakness limiting our ability to study
patient-specific growth patterns is that we analyzed
aggregate patient data. The ideal method for studying
polyp growth would be to use serial measurements over
time in individual patients. But as pointed out pre-
viously, because of ethical considerations, such studies
have rarely been performed.
In this study we studied the size of the largest polyp
detected at screening colonoscopy performed in a large
sample of patients in various practice settings. Although
it is impossible to make exact inferences about polyp
growth rates from our cross-sectional data, the observed
age-related changes in mean polyp size serve as a surro-
gate measure of polyp growth. In our study younger
patients are likely to have smaller polyps and there
appears to be a linear relationship between age and
polyp size. Overall polyp size increased gradually with
age, and other factors such as gender, race, location of
polyp, and the number of polyps were strong indepen-
dent predictors of polyp size. Our data suggest that for
many patients, several decades must elapse before a
polyp initially measuring ≥ 5 mm attains a size where
there is a significant risk of advanced pathology.
Decision models of colorectal screening make assump-
tions about polyp dwell time to help determine intervals
between examinations. These data provide quantitative
information about polyp duration which may prove useful
for future decision models. The data also includes infor-
mation about other variables that might help clinicians
and policy makers determine the timing of initial colono-
scopy, the frequency of follow-up procedures, and the
most suitable screening procedure for individual patients.
Conclusions
Our results indicate that polyp size is related to several
factors including race, and gender and that there appears
to be a nearly linear relationship between polyp size and
age. The strongest risk factor for increasing polyp size
over time was the presence of multiple polyps. Our find-
ings suggest that small polyps will require several decades
before attaining clinically significant size. The study aug-
ments existing information about determinants of polyp
size and can help adjust screening recommendations
based upon individual patient parameters.
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